» Articles » PMID: 23626469

Stress-induced Cardiomyopathy (Takotsubo)--broken Heart and Mind?

Overview
Publisher Dove Medical Press
Date 2013 Apr 30
PMID 23626469
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Stress-induced cardiomyopathy (SIC), also known as Takotsubo cardiomyopathy, is characterized by severe but potentially reversible regional left ventricular wall motion abnormalities, ie, akinesia, in the absence of explanatory angiographic evidence of a coronary occlusion. The typical pattern is that of an akinetic apex with preserved contractions in the base, but other variants are also common, including basal or midmyocardial akinesia with preserved apical function. The pathophysiology of SIC remains largely unknown but catecholamines are believed to play a pivotal role. The diverse array of triggering events that have been linked to SIC are arbitrarily categorized as either emotional or somatic stressors. These categories can be considered as different elements of a continuous spectrum, linked through the interface of neurology and psychiatry. This paper reviews our current knowledge of SIC, with focus on the intimate relationship between the brain and the heart.

Citing Articles

An ophthalmologist with myocardial bridging developed takotsubo cardiomyopathy while operating; A case report and literature review.

Al-Sadi A, Al-Qahtani A, Al-Khalaila O, Jawarneh I, Karim S Clin Case Rep. 2023; 11(11):e7353.

PMID: 38028065 PMC: 10665582. DOI: 10.1002/ccr3.7353.


Broken Heart Syndrome: Evolving Molecular Mechanisms and Principles of Management.

Sethi Y, Murli H, Kaiwan O, Vora V, Agarwal P, Chopra H J Clin Med. 2023; 12(1).

PMID: 36614928 PMC: 9821117. DOI: 10.3390/jcm12010125.


Molecular Mechanisms of Takotsubo Syndrome.

Couch L, Channon K, Thum T Int J Mol Sci. 2022; 23(20).

PMID: 36293121 PMC: 9603071. DOI: 10.3390/ijms232012262.


Quantitative Lipidomic Analysis of Takotsubo Syndrome Patients' Serum.

Karnati S, Guntas G, Rajendran R, Shityakov S, Horing M, Liebisch G Front Cardiovasc Med. 2022; 9:797154.

PMID: 35514439 PMC: 9062978. DOI: 10.3389/fcvm.2022.797154.


Takotsubo Cardiomyopathy: Current Treatment.

Madias J J Clin Med. 2021; 10(15).

PMID: 34362223 PMC: 8347171. DOI: 10.3390/jcm10153440.


References
1.
Omerovic E . How to think about stress-induced cardiomyopathy?--Think "out of the box"!. Scand Cardiovasc J. 2011; 45(2):67-71. DOI: 10.3109/14017431.2011.565794. View

2.
Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nakama Y . Prevalence of incidental coronary artery disease in tako-tsubo cardiomyopathy. Coron Artery Dis. 2009; 20(3):214-8. DOI: 10.1097/MCA.0b013e3283299260. View

3.
Page D, CAULFIELD J, Kastor J, DESANCTIS R, Sanders C . Myocardial changes associated with cardiogenic shock. N Engl J Med. 1971; 285(3):133-7. DOI: 10.1056/NEJM197107152850301. View

4.
Summers M, Lennon R, Prasad A . Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential pre-disposing factors?. J Am Coll Cardiol. 2010; 55(7):700-1. DOI: 10.1016/j.jacc.2009.10.031. View

5.
Lyon A, Rees P, Prasad S, Poole-Wilson P, Harding S . Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med. 2007; 5(1):22-9. DOI: 10.1038/ncpcardio1066. View